-
Signature
-
/s/ Jonathan Young, Attorney-in-Fact
-
Issuer symbol
-
AKRO
-
Transactions as of
-
08 Sep 2025
-
Net transactions value
-
-$362,371
-
Form type
-
4
-
Filing time
-
10 Sep 2025, 19:48:04 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rolph Timothy |
Chief Scientific Officer |
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO |
/s/ Jonathan Young, Attorney-in-Fact |
10 Sep 2025 |
0001779479 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AKRO |
Common Stock |
Options Exercise |
$148,558 |
+7,044 |
+4.2% |
$21.09 |
174,168 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
AKRO |
Common Stock |
Options Exercise |
$32,845 |
+5,161 |
+3% |
$6.36 |
179,329 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
AKRO |
Common Stock |
Options Exercise |
$8,363 |
+295 |
+0.16% |
$28.35 |
179,624 |
08 Sep 2025 |
Direct |
F1 |
| transaction |
AKRO |
Common Stock |
Sale |
$550,611 |
-12,466 |
-6.9% |
$44.17 |
167,158 |
08 Sep 2025 |
Direct |
F1, F2 |
| transaction |
AKRO |
Common Stock |
Sale |
$1,526 |
-34 |
-0.02% |
$44.88 |
167,124 |
08 Sep 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AKRO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-7,044 |
-95% |
$0.000000 |
389 |
08 Sep 2025 |
Common Stock |
7,044 |
$21.09 |
Direct |
F1, F3 |
| transaction |
AKRO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-295 |
-0.47% |
$0.000000 |
62,445 |
08 Sep 2025 |
Common Stock |
295 |
$28.35 |
Direct |
F1, F3 |
| transaction |
AKRO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,161 |
-100% |
$0.000000 |
0 |
08 Sep 2025 |
Common Stock |
5,161 |
$6.36 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: